+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cytoskeleton antibodies in chronic active hepatitis primary biliary cirrhosis and alcoholic liver disease



Cytoskeleton antibodies in chronic active hepatitis primary biliary cirrhosis and alcoholic liver disease



Hepatology 3(3): 297-302



Antibodies to cytoplasmic microfilaments, intermediate filaments (vimentin filaments) and microtubules which comprise the cytoskeleton of the cell were assayed in sera from 23 patients with HBsAg[hepatitis B surface antigen]-negative chronic active hepatitis and 1 with HBsAg-positive chronic active hepatitis, 15 patients with primary biliary cirrhosis, 20 patients with alcoholic liver disease and 32 healthy controls. The cytoskeleton antibodies were assayed by indirect immunofluorescence technique using vinblastine-treated cultured human embryonic fibroblasts as substrates. There was a significantly increased incidence of cytoskeleton antibodies in patients with liver disease compared to the control group. Antibodies to microfilaments were found frequently in sera from patients with chronic active hepatitis (67%) and primary biliary cirrhosis (53%) but were rare in sera from patients with alcoholic liver disease (25%) and in control sera (3%). Antibodies to microtubules were found in 50% of sera from patients with alcoholic liver disease but in only 7 to 13% of sera from other groups. Intermediate filament antibodies of IgG or IgA class were found only in patient sera whereas intermediate filament antibodies of IgM class were found in the majority of sera in all groups including control sera. The highest titers of intermediate filament antibodies were seen in primary biliary cirrhosis and chronic active hepatitis. The production of cytoskeleton antibodies may be due to the reorganization or destruction of cytoskeletal structures in the liver.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 005088696

Download citation: RISBibTeXText

PMID: 6341195

DOI: 10.1002/hep.1840030304


Related references

Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease. Liver 4(2): 134-138, 1984

Serum free thyroid hormone concentrations and indices in alcoholic liver cirrhosis, primary biliary cirrhosis and chronic active hepatitis. Acta Endocrinologica. Supplementum 251: 21-26, 1983

Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clinical and Experimental Immunology 1(3): 237-262, 1966

Cellular and humoral immune reactions in chronic active liver disease 1. lymphocyte subsets in liver biopsies of patients with untreated idiopathic auto immune hepatitis chronic active hepatitis b and primary biliary cirrhosis. Clinical and Experimental Immunology 50(1): 17-24, 1982

Chronic hepatitis with histological picture resembling primary biliary cirrhosis a well definite subgroup among cryptogenic chronic alcoholic liver disease. Journal of Hepatology (Suppl. 2): S232, 1985

Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer 115(19): 4564-4575, 2009

Detection of antibodies to hepatitis E virus in patients with autoimmune chronic active hepatitis and primary biliary cirrhosis. Scandinavian Journal of Gastroenterology 32(4): 387-389, 1997

Antibodies to cytoplasmic antigens in primary biliary cirrhosis and chronic active hepatitis. Journal of Laboratory and Clinical Medicine 69(6): 979-988, 1967

Anti cytoplasmic antibodies in chronic active hepatitis and primary biliary cirrhosis. Clinical Research: 761a, 1978

M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: Epitopes or epiphenomena?. Hepatology 16(5): 1128-1136, 1992

Biliary lipids, faecal steroids, and liver function in patients with chronic active hepatitis and primary biliary cirrhosis: significance of hepatic orcein-stained complexes. Gut 22(7): 579-584, 1981

Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance. Gut 21(10): 878-884, 1980

Estimating survival in patients with primary biliary cirrhosis primary sclerosing cholangitis and autoimmune chronic active hepatitis application to liver transplantation. Hepatology 5(5): 1020, 1985

Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis. Gastroenterology 78(5 Pt 1): 1034-1040, 1980

Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. European Journal of Immunology 18(9): 1447-1452, 1988